Cyclic Peptide Anti-Inflammatory Drugs Can Be Delivered Through the Skin
Small macrocyclic C5a complement antagonists achieved meaningful transdermal delivery in rats, demonstrating that cyclic peptide drugs can penetrate skin — opening topical administration for anti-inflammatory peptide therapy.
Quick Facts
What This Study Found
Macrocyclic C5a antagonists achieved pharmacologically active transdermal penetration in rats, with measurable anti-inflammatory effects from topical application — establishing the feasibility of transdermal delivery for cyclic peptide anti-inflammatory drugs.
Key Numbers
How They Did This
animal-study study on cyclic-peptides, inflammation.
Why This Research Matters
Relevant for cyclic-peptides, inflammation, peptide-delivery.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
- ?Clinical translation to evaluate.
Trust & Context
- Key Stat:
- Key finding Macrocyclic C5a antagonists achieved pharmacologically active transdermal penetration in rats, with measurable anti-inflammatory effects from topical
- Evidence Grade:
- preliminary evidence.
- Study Age:
- Published in 2006.
- Original Title:
- Transdermal pharmacology of small molecule cyclic C5a antagonists.
- Published In:
- Advances in experimental medicine and biology, 586, 329-45 (2006)
- Database ID:
- RPEP-01178
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What was studied?
Cyclic Peptide Anti-Inflammatory Drugs Can Be Delivered Through the Skin
What was found?
Small macrocyclic C5a complement antagonists achieved meaningful transdermal delivery in rats, demonstrating that cyclic peptide drugs can penetrate skin — opening topical administration for anti-inflammatory peptide therapy.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-01178APA
Proctor, Lavinia M; Woodruff, Trent M; Sharma, Prakirti; Shiels, Ian A; Taylor, Stephen M. (2006). Transdermal pharmacology of small molecule cyclic C5a antagonists.. Advances in experimental medicine and biology, 586, 329-45.
MLA
Proctor, Lavinia M, et al. "Transdermal pharmacology of small molecule cyclic C5a antagonists.." Advances in experimental medicine and biology, 2006.
RethinkPeptides
RethinkPeptides Research Database. "Transdermal pharmacology of small molecule cyclic C5a antago..." RPEP-01178. Retrieved from https://rethinkpeptides.com/research/proctor-2006-transdermal-pharmacology-of-small
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.